Literature DB >> 25899773

Atypical fibrodysplasia ossificans progressiva diagnosed by whole-exome sequencing.

Hao Liu1, Sarah L Sawyer2,3, Monika Gos4, David Grynspan5, Kheirie Issa6, Raveena Ramphal7, Carmen Rotaru8, Jacek Majewski9, Kym M Boycott2,3, Gail Graham2,3, Matthew Bromwich10.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by congenital malformations of the great toes and progressive heterotopic ossification of connective tissue that begins during the first decade of life. Our patient presented with intrauterine growth retardation, respiratory distress, neonatal onset soft tissue masses, bilateral hallux valgus, and congenital anomalies of the thyroid and uterus. She was initially diagnosed with atypical infantile myofibromatosis based on clinical and pathological findings. She underwent whole-exome sequencing (WES) as part of the FORGE study to identify the gene for infantile myofibromatosis; however a de novo dominant mutation in ACVR1 (NM_001105.4:c.617G>A) revised the diagnosis to FOP. This patient highlights the utility of WES as an early diagnostic tool in the investigation of patients with unusual presentations of rare diseases, thereby providing clinicians with accurate molecular diagnoses and the opportunity to tailor clinical management to improve patient care.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  fibrodysplasia ossificans progressiva; hallux valgus; heterotopic ossification; whole exome sequencing

Mesh:

Substances:

Year:  2015        PMID: 25899773     DOI: 10.1002/ajmg.a.36969

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

Review 1.  Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.

Authors:  Zijuan Qi; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

2.  DNM1L-related mitochondrial fission defect presenting as refractory epilepsy.

Authors:  Jason R Vanstone; Amanda M Smith; Skye McBride; Turaya Naas; Martin Holcik; Ghadi Antoun; Mary-Ellen Harper; Jean Michaud; Erick Sell; Pranesh Chakraborty; Martine Tetreault; Jacek Majewski; Stephen Baird; Kym M Boycott; David A Dyment; Alex MacKenzie; Matthew A Lines
Journal:  Eur J Hum Genet       Date:  2015-11-25       Impact factor: 4.246

3.  Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.

Authors:  János Molnár; Gergely Szakács; Gábor E Tusnády
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

Review 4.  NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.

Authors:  Ana Fernandez-Marmiesse; Sofia Gouveia; Maria L Couce
Journal:  Curr Med Chem       Date:  2018-01-30       Impact factor: 4.530

5.  A rare presentation: A case report of osseous metaplasia and mature bone formation in a follicular adenoma of the thyroid.

Authors:  Nadia Aurora; Insia Hashmi; Subhasis Misra; Nail Aydin
Journal:  Int J Surg Case Rep       Date:  2017-06-17

Review 6.  Application of Next Generation Sequencing in Laboratory Medicine.

Authors:  Yiming Zhong; Feng Xu; Jinhua Wu; Jeffrey Schubert; Marilyn M Li
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

Review 7.  Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.

Authors:  S L Sawyer; T Hartley; D A Dyment; C L Beaulieu; J Schwartzentruber; A Smith; H M Bedford; G Bernard; F P Bernier; B Brais; D E Bulman; J Warman Chardon; D Chitayat; J Deladoëy; B A Fernandez; P Frosk; M T Geraghty; B Gerull; W Gibson; R M Gow; G E Graham; J S Green; E Heon; G Horvath; A M Innes; N Jabado; R H Kim; R K Koenekoop; A Khan; O J Lehmann; R Mendoza-Londono; J L Michaud; S M Nikkel; L S Penney; C Polychronakos; J Richer; G A Rouleau; M E Samuels; V M Siu; O Suchowersky; M A Tarnopolsky; G Yoon; F R Zahir; J Majewski; K M Boycott
Journal:  Clin Genet       Date:  2015-09-22       Impact factor: 4.438

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.